We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
Prostate cancers, several endometrial and liver cancers along with a few breast, lung, renal and stomach cancers displayed weak to moderate cytoplasmic positivity, often with a granular pattern. Single cases of carcinoid and endometroid adenocarcinoma of ovary were strongly stained. Remaining tumor cells were mainly negative.
Weak to moderate cytoplasmic immunoreactivity, often with a granular pattern was observed in prostate cancers along with several liver, colorectal, lung, stomach, endometrial and breast cancers. Remaining cancer tissues were generally negative.
GENE INFORMATION
Gene name
HEXB
Synonyms
Description
Hexosaminidase B (beta polypeptide) (HGNC Symbol)
Entrez gene summary
Hexosaminidase B is the beta subunit of the lysosomal enzyme beta-hexosaminidase that, together with the cofactor GM2 activator protein, catalyzes the degradation of the ganglioside GM2, and other molecules containing terminal N-acetyl hexosamines. Beta-hexosaminidase is composed of two subunits, alpha and beta, which are encoded by separate genes. Both beta-hexosaminidase alpha and beta subunits are members of family 20 of glycosyl hydrolases. Mutations in the alpha or beta subunit genes lead to an accumulation of GM2 ganglioside in neurons and neurodegenerative disorders termed the GM2 gangliosidoses. Beta subunit gene mutations lead to Sandhoff disease (GM2-gangliosidosis type II). Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2014]